中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2013年
5期
261-264
,共4页
李彦博%刘霏霏%刘垚%曲恒燕%高洪志%刘泽源
李彥博%劉霏霏%劉垚%麯恆燕%高洪誌%劉澤源
리언박%류비비%류요%곡항연%고홍지%류택원
蛋氨酸脑啡肽%SH-SY5Y细胞株%G0/G1期%P21%P16%P53%抑制作用
蛋氨痠腦啡肽%SH-SY5Y細胞株%G0/G1期%P21%P16%P53%抑製作用
단안산뇌배태%SH-SY5Y세포주%G0/G1기%P21%P16%P53%억제작용
Methionine enkephalin%SH-SY5Y cell lines%G0/G1 phase%P21%P16%P53%Inhibition
目的::研究蛋氨酸脑啡肽(Met-ENK)对神经母细胞瘤细胞SH-SY5Y的生长抑制作用及细胞周期的抑制机制。方法:采用MTT法检测细胞生长抑制率;流式细胞术检测Met-ENK作用后肿瘤细胞周期变化;Real-time PCR法检测Met-ENK作用后细胞内P21,P53基因转录量变化;Western blot法检测细胞内P21,P16,磷酸Rb蛋白表达量的变化情况。结果:MTT法结果显示,Met-ENK对SH-SY5Y细胞有生长抑制作用,在Met-ENK浓度为10-5 mol· L-1时抑制率为40%;流式细胞术证实Met-ENK作用后大多数细胞被抑制于细胞周期的G0/G1期,该期细胞数由63.97%变为87.73%;P21的基因转录量是用药前的3倍,P53基因转录量是用药前的5倍;P21,P16蛋白表达量明显增加,磷酸Rb蛋白表达量明显降低。结论:Met-ENK可以通过上调细胞周期蛋白依靠性激酶抑制因子P21及抑癌基因P53的转录和蛋白表达量,下调Rb蛋白的磷酸化水平将SH-SY5Y细胞的增殖抑制于生长周期的G0/G1期,表明Met-ENK的G0/G1期特异性周期抑瘤作用可以通过调节该途径产生。
目的::研究蛋氨痠腦啡肽(Met-ENK)對神經母細胞瘤細胞SH-SY5Y的生長抑製作用及細胞週期的抑製機製。方法:採用MTT法檢測細胞生長抑製率;流式細胞術檢測Met-ENK作用後腫瘤細胞週期變化;Real-time PCR法檢測Met-ENK作用後細胞內P21,P53基因轉錄量變化;Western blot法檢測細胞內P21,P16,燐痠Rb蛋白錶達量的變化情況。結果:MTT法結果顯示,Met-ENK對SH-SY5Y細胞有生長抑製作用,在Met-ENK濃度為10-5 mol· L-1時抑製率為40%;流式細胞術證實Met-ENK作用後大多數細胞被抑製于細胞週期的G0/G1期,該期細胞數由63.97%變為87.73%;P21的基因轉錄量是用藥前的3倍,P53基因轉錄量是用藥前的5倍;P21,P16蛋白錶達量明顯增加,燐痠Rb蛋白錶達量明顯降低。結論:Met-ENK可以通過上調細胞週期蛋白依靠性激酶抑製因子P21及抑癌基因P53的轉錄和蛋白錶達量,下調Rb蛋白的燐痠化水平將SH-SY5Y細胞的增殖抑製于生長週期的G0/G1期,錶明Met-ENK的G0/G1期特異性週期抑瘤作用可以通過調節該途徑產生。
목적::연구단안산뇌배태(Met-ENK)대신경모세포류세포SH-SY5Y적생장억제작용급세포주기적억제궤제。방법:채용MTT법검측세포생장억제솔;류식세포술검측Met-ENK작용후종류세포주기변화;Real-time PCR법검측Met-ENK작용후세포내P21,P53기인전록량변화;Western blot법검측세포내P21,P16,린산Rb단백표체량적변화정황。결과:MTT법결과현시,Met-ENK대SH-SY5Y세포유생장억제작용,재Met-ENK농도위10-5 mol· L-1시억제솔위40%;류식세포술증실Met-ENK작용후대다수세포피억제우세포주기적G0/G1기,해기세포수유63.97%변위87.73%;P21적기인전록량시용약전적3배,P53기인전록량시용약전적5배;P21,P16단백표체량명현증가,린산Rb단백표체량명현강저。결론:Met-ENK가이통과상조세포주기단백의고성격매억제인자P21급억암기인P53적전록화단백표체량,하조Rb단백적린산화수평장SH-SY5Y세포적증식억제우생장주기적G0/G1기,표명Met-ENK적G0/G1기특이성주기억류작용가이통과조절해도경산생。
Objective:To study the cell growth inhibition and cell cycle inhibitory mechanisms of methionine enkephalin (Met-ENK) on SH-SY5Y cell. Methods:MTT assay was used for detecting the cell growth inhibition rate, the change of tumor cell cycle was detected by flow cytometry, the levels of intracellular P21 and P53 gene transcript were analyzed by Real-time PCR, the expressions of intracellular P21, P16 and phosphorylated Rb protein were determined using Western blot assay after intervention with Met-ENK. Results:MTT assay showed that Met-ENK could inhibit SH-SY5Y cell growth, and the inhibition rate was 40%at the Met-ENK concentration of 10-5 mol·L-1. The results of flow cytometry confirmed that most of cells were blocked in G0/G1 phase, and the number of cells in G0/G1 phase increased from 63.97%to 87.73%. The transcript levels of P21 gene and P53 gene were three and five times higher than that before intervention with Met-ENK. The expressions of P21 and P16 protein significantly increased, while expression of phosphorylation Rb protein significantly reduced. Conclusion: Met-ENK could inhibit the SH-SY5Y cell proliferation in the G0/G1 phase of the growth cycle by increasing the transcription and protein expression of the cyclin-dependent kinase inhibitor-P21 and tumor suppressor gene-P53 and decreasing the level of Rb protein phosphorylation, which confirmed the mechanism of G0/G1 phase specificity cycle inhibitory effect of Met-ENK.